首页> 外文期刊>Drug Design, Development and Therapy >Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
【24h】

Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome

机译:宣白承气汤对外源性肺急性呼吸窘迫综合征患者肺顺应性的影响

获取原文
           

摘要

Objective: To observe the effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome. Subjects and methods: A total of 53 patients with exogenous pulmonary acute respiratory distress syndrome, who were admitted to the intensive care unit of the First Affiliated Hospital of Henan University of Traditional Chinese Medicine from March 2009 to February 2013, were selected. They were randomly divided into the treatment group (25 cases) and the control group (28 cases). Both?the groups were treated with conventional treatment and lung-protective ventilation strategy; apart from these, enema therapy with Xuanbai Chengqi decoction was given to the treatment group. Meanwhile, static lung compliance, dynamic lung compliance, peak airway pressure, plateau pressure, and positive end-expiratory pressure (PEEP) for patients in both the groups were observed and recorded at 24, 48, and 72?hours after the drug was used. Moreover, variations in the duration of parenteral nutrition, incidence rate of complications, and case fatality rate in patients after treatment were recorded. Results: For patients in the treatment group, at 48?and 72?hours after treatment, the static lung compliance and dynamic lung compliance were significantly higher than those in the control group, while plateau pressure, peak airway pressure, and PEEP were significantly lower than those before treatment. At the same time, PEEP for patients in the treatment group at 72?hours after treatment was remarkably lower than that in the control group, showing significant difference ( P <0.05). The duration of parenteral nutrition in the treatment group was significantly shorter than that in the control group ( P <0.05). Both the incidence rate and the fatality rate of complications, such as abdominal distension and ventilator-associated pneumonia, for patients in the treatment group were distinctly smaller than those in the control group ( P <0.05). Conclusion: Xuanbai Chengqi decoction not only can improve the static lung compliance and dynamic compliance of patients with exogenous pulmonary distress syndrome but also can shorten the parenteral nutrition duration, as well as reducing the complication incidence rate and fatality rate.
机译:目的:观察宣白承气汤对外源性肺急性呼吸窘迫综合征患者肺顺应性的影响。研究对象和方法:选择2009年3月至2013年2月在河南中医药大学附属第一医院重症监护病房就诊的53例外源性肺急性呼吸窘迫综合征患者。将他们随机分为治疗组(25例)和对照组(28例)。两组均采用常规治疗和肺保护通气策略治疗。除此以外,治疗组还采用宣白承气汤灌肠治疗。同时,观察两组患者在使用药物后24、48和72小时的静态肺顺应性,动态肺顺应性,峰值气道压力,平台压和呼气末正压(PEEP),并进行记录。 。此外,记录了治疗后患者肠胃外营养持续时间,并发症发生率和病死率的变化。结果:对于治疗组的患者,在治疗后48和72小时,静态肺顺应性和动态肺顺应性显着高于对照组,而高原压力,峰值气道压力和PEEP则明显降低。比治疗前的那些。同时,治疗后72小时,治疗组患者的PEEP显着低于对照组,差异有统计学意义(P <0.05)。治疗组胃肠外营养时间明显短于对照组(P <0.05)。治疗组患者腹胀和呼吸机相关性肺炎等并发症的发生率和死亡率均明显低于对照组(P <0.05)。结论:宣白承气汤不仅可以改善外源性肺窘迫综合征患者的静态肺顺应性和动态顺应性,还可以缩短肠外营养时间,降低并发症的发生率和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号